A retrospective analysis of cisplatin, pemetrexed, and bevacizumab in previously treated non-small-cell lung cancer

Por Liu, Ke-Jun, Wu, Hai-Ying
Publicado no Oncotarget (2015)

Targeted therapy of multiple liver metastases after resected solitary gastric metastasis and primary pulmonary adenocarcinoma

Por Ding, Ling-yu, Liu, Ke-jun, Jiang, Zhe-long, Wu, Hai-ying, Wu, Shi-xiu
Publicado no Oncotarget (2016)

Treatment strategies and prognostic factors of patients with primary germ cell tumors in the mediastinum

Por Liu, Ting Zhi, Zhang, Dong Sheng, Liang, Ying, Zhou, Ning Ning, Gao, Hong Fei, Liu, Ke Jun, Wu, Hai Ying
Publicado em 2011

Saracatinib (AZD0530) Is a Potent Modulator of ABCB1-mediated Multidrug Resistance in Vitro and in Vivo

Por Liu, Ke-jun, He, Jie-hua, Su, Xiao-dong, Sim, Hong-May, Xie, Jing-dun, Chen, Xing-gui, Wang, Fang, Liang, Yong-ju, Singh, Satyakam, Sodani, Kamlesh, Talele, Tanaji T., Ambudkar, Suresh V., Chen, Zhe-Sheng, Wu, Hai-Ying, Fu, Li-wu
Publicado em 2012

A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung c...

Por Liu, Ke-Jun, Guan, Zhong-Zhen, Liang, Ying, Yang, Xu-Qing, Peng, Jin, Huang, He, Shao, Qing-Xiang, Wang, Meng-Zhao, Zhu, Yun-Zhong, Wu, Chang-Ping, Wang, Shao-Bin, Xiong, Jian-Ping, Bai, Yu-Xian, Yu, Shi-Ying, Zhang, Yang, Hu, Xiao-Hua, Feng, Ji-Feng, Wu, Shi-Xiu, Jiao, Shun-Chang, Zhou, Cai-Cun, Wang, Jie, Wu, Hai-Ying
Publicado em 2014